You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%


✉ Email this page to a colleague

« Back to Dashboard


POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% potassium chloride; sodium chloride INJECTABLE;INJECTION 017648 NDA Baxter Healthcare Company 0338-0691-04 14 BAG in 1 CARTON (0338-0691-04) / 1000 mL in 1 BAG 1979-02-02
Baxter Hlthcare POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% potassium chloride; sodium chloride INJECTABLE;INJECTION 017648 NDA Baxter Healthcare Company 0338-0695-04 14 BAG in 1 CARTON (0338-0695-04) / 1000 mL in 1 BAG 1979-02-02
Baxter Hlthcare POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% potassium chloride; sodium chloride INJECTABLE;INJECTION 017648 NDA Baxter Healthcare Company 0338-0704-34 14 BAG in 1 CARTON (0338-0704-34) / 1000 mL in 1 BAG 1979-02-02
Fresenius Kabi Usa POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% potassium chloride; sodium chloride INJECTABLE;INJECTION 212347 ANDA Fresenius Kabi USA, LLC 63323-683-10 10 BAG in 1 CARTON (63323-683-10) / 1000 mL in 1 BAG (63323-683-01) 2021-06-02
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Pharmaceutical Drugs: Potassium Chloride 0.3% and Sodium Chloride 0.9%

Last updated: July 30, 2025

Introduction

In the pharmaceutical industry, sourcing reliable and compliant suppliers for high-quality active pharmaceutical ingredients (APIs) and finished sterile preparations is crucial. Potassium Chloride 0.3% and Sodium Chloride 0.9% are widely used intravenous fluids, primarily for maintaining electrolyte balance and hydration. Understanding the landscape of global suppliers for these solutions enables pharmaceutical companies, healthcare providers, and distributors to optimize procurement strategies, ensure regulatory compliance, and mitigate supply chain risks.

Market Overview of Potassium Chloride 0.3% and Sodium Chloride 0.9%

Potassium chloride (KCl) and sodium chloride (NaCl) solutions are integral to clinical care. Sodium chloride 0.9%—often called "normal saline"—is the most common IV fluid, used for fluid replacement and as a diluent for medications. Potassium chloride 0.3% is frequently administered to correct hypokalemia or maintain electrolyte balance.

The global demand for these saline solutions correlates with healthcare spending, hospital capacity, and aging populations. The supply chain is characterized by a mix of large, diversified pharmaceutical manufacturers and specialized contract manufacturing organizations (CMOs).

Major Suppliers and Manufacturers

Global Pharmaceutical Giants

  1. Baxter International Inc.
    Baxter is a leading manufacturer of IV fluids, including sodium chloride and potassium chloride solutions. Their product line conforms to stringent regulatory standards, including FDA, EMA, and WHO approvals. Baxter’s extensive manufacturing network ensures broad global distribution.

  2. B. Braun Melsungen AG
    B. Braun supplies a wide range of sterile infusion solutions, including isotonic saline and potassium chloride infusions. Their products are recognized for high purity and compliance with international standards.

  3. Pfizer Inc. (Hospira)
    Now part of Pfizer, Hospira was historically a key supplier of IV solutions. The product portfolio includes saline solutions produced under strict quality controls suitable for hospital use worldwide.

  4. Fresenius Kabi
    A prominent manufacturer, Fresenius supplies sterile, ready-to-use saline solutions and electrolyte products with a focus on quality and global regulatory compliance.

  5. Baxter Healthcare
    As a major player in infusion therapy, Baxter offers sodium chloride and potassium chloride solutions that meet diverse regulatory and manufacturing standards.

Specialized Contract Manufacturing Organizations (CMOs)

  • Glenmark
    Provides both APIs and finished IV solutions, including customized saline formulations with potassium and sodium chloride.

  • Teva Pharmaceuticals
    Focuses on sterile infusion solutions, with a significant presence in generics and contract manufacturing.

  • Baxter and Hikma
    Collaborate with local manufacturing facilities across Middle Eastern and Asian markets to ensure regional supply.

Regional and Local Suppliers

Many regional pharmaceutical manufacturers produce saline solutions, especially for local markets in India, China, and Southeast Asia. These suppliers often comply with regional regulatory standards like China's CFDA, India's DCGI, or the European CE marking.

Key Considerations When Selecting Suppliers

  • Regulatory Compliance: Ensure suppliers adhere to Good Manufacturing Practices (GMP), FDA approvals, and regional standards.
  • Product Quality: Confirm sterility, pH balance, endotoxin levels, and shelf stability.
  • Supply Chain Reliability: Evaluate lead times, inventory management, and geographic proximity to mitigate shortages.
  • Pricing and Contract Terms: Competitive pricing without compromising quality, including volume discounts and flexible delivery schedules.
  • Labeling and Documentation: Accurate labeling compliant with regional requirements and comprehensive documentation for regulatory submissions.

Emerging Trends and Challenges

  • Regulatory Harmonization: Increasing global convergence of standards facilitates international procurement but requires compliance with multiple regulatory regimes.
  • Supply Chain Disruptions: The COVID-19 pandemic exposed fragilities; diversified sourcing and local manufacturing are vital.
  • Sustainability and Quality Assurance: Growing emphasis on environmentally sustainable processes influences supplier selection and product lifecycle management.
  • API vs. Finished Product: Some suppliers focus on active ingredients, while others supply ready-to-use sterile preparations, impacting procurement strategies.

Conclusion

The procurement of potassium chloride 0.3% and sodium chloride 0.9% solutions necessitates a comprehensive understanding of the global supplier landscape, regulatory considerations, and market dynamics. Leading multinational corporations such as Baxter, B. Braun, and Fresenius dominate the market, offering high-quality, compliant products. Contract manufacturing organizations and regional suppliers provide additional flexibility and localized supply options. Strategic supplier selection hinges on regulatory adherence, product quality, reliable supply chains, and cost-effectiveness.


Key Takeaways

  • Leading Global Suppliers: Baxter, B. Braun, Fresenius Kabi, and Pfizer (Hospira) remain the primary sources of sterile saline solutions for international markets.
  • Regulatory and Quality Standards: Stringent compliance (GMP, FDA, EMA) is non-negotiable for pharmaceutical procurement.
  • Diversification Reduces Risk: Engaging multiple suppliers and regional manufacturers mitigates supply chain interruptions.
  • Emerging Trends: Growing regulatory harmonization and sustainable manufacturing practices influence supplier choices.
  • Strategic Procurement: Combining API sourcing with finished product procurement enhances supply stabilization and regulatory compliance.

FAQs

1. How do I verify the quality and regulatory compliance of a saline solution supplier?
Verify supplier certifications, such as GMP and equivalent regional approvals, conduct audits if possible, review quality assurance documentation, and ensure products meet pharmacopoeial standards (USP, EP, JP).

2. Are regional manufacturers suitable for critical hospital supplies?
Yes, if they meet international quality standards and certifications. Regional suppliers can provide cost-effective and timely options, especially for localized markets.

3. What factors should influence supplier selection for potassium and sodium chloride solutions?
Regulatory compliance, product quality, supply reliability, pricing, company reputation, and logistics are key factors.

4. How has COVID-19 impacted the supply chain for saline solutions?
Disruptions prompted diversification of suppliers, increased focus on local manufacturing, and a push for stockpile reserves to mitigate shortages.

5. Is API sourcing important for saline solutions?
Typically, saline solutions are formulated from pharmaceutical-grade salts. API sourcing is crucial if custom formulations or electrolyte concentrations are required beyond standard solutions.


References

  1. [1] "Global Market Analysis for IV Solutions," Pharmaceutical Technology, 2022.
  2. [2] "Regulatory Standards for Injectable Solutions," WHO Guidelines, 2021.
  3. [3] "Leading Manufacturers of IV Fluids," Industry Reports, 2022.
  4. [4] "Impact of COVID-19 on Global Pharmaceutical Supply Chains," McKinsey & Company, 2021.
  5. [5] "Sustainability Initiatives in Pharmaceutical Manufacturing," Green Pharma Journal, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.